05th week of 2020 patent applcation highlights part 9 |
Patent application number | Title | Published |
20200030289 | COMPOSITIONS AND METHODS FOR PROMOTING HAIR GROWTH WITH MPC1 INHIBITORS | 2020-01-30 |
20200030290 | INDAZOLE AND INDOLE DERIVATIVES AS INHIBITORS OF RETINOIC ACID RELATED ORPHAN RECEPTOR GAMMA (ROR GAMMA) FOR THE TREATMENT OF IMMUNE-RELATED DISEASES | 2020-01-30 |
20200030291 | 20-HETE RECEPTOR (GPR75) ANTAGONISTS AND METHODS OF USE | 2020-01-30 |
20200030292 | GFI1 INHIBITORS FOR THE TREATMENT OF HYPERGLYCEMIA | 2020-01-30 |
20200030293 | THERAPEUTIC OR PROPHYLACTIC AGENT FOR PERIPHERAL NEUROPATHIES | 2020-01-30 |
20200030294 | TREATMENT FOR WOLFRAM SYNDROME AND OTHER ENDOPLASMIC RETICULUM STRESS DISORDERS | 2020-01-30 |
20200030295 | HETEROCYCLIC DIAMIDINES | 2020-01-30 |
20200030296 | COMPOSITIONS FOR THE TREATMENT OF HYPERTENSION | 2020-01-30 |
20200030297 | NOVEL COMPOUNDS, COMPOSITIONS AND METHODS FOR TREATING INSULIN RESISTANCE | 2020-01-30 |
20200030298 | Compositions and Methods of Treating Muscular Dystrophy with Thromboxane-A2 Receptor Antagonists | 2020-01-30 |
20200030299 | AGENT FOR REDUCING VISCERAL FAT WEIGHT | 2020-01-30 |
20200030300 | AMINE SALT OF (1R, 3S)-3-(5-CYANO-4-PHENYL-1,3-THIAZOL-2-YLCARBAMOYL)CYCLOPENTANE CARBOXYLIC ACID | 2020-01-30 |
20200030301 | COMBINATION OF IBUDILAST AND RILUZOLE AND METHODS OF USING SAME | 2020-01-30 |
20200030302 | Treating Gastric Cancer Using Combination Therapies Comprising Liposomal Irinotecan, Oxaliplatin, 5-Fluoruracil (and Leucovorin) | 2020-01-30 |
20200030303 | COMPOSITIONS AND METHODS FOR INHIBITING PROTEIN KINASES | 2020-01-30 |
20200030304 | MITIGATION OF CNS DISORDERS BY COMBINATION THERAPY USING NEUROSTEROIDS, AND AMPA BLOCKERS | 2020-01-30 |
20200030305 | LOCAL ANESTHETIC-CONTAINING ACIDIC EMULSION COMPOSITION | 2020-01-30 |
20200030306 | 1-[(PYRIDIN-3-YL-SULFONYL)-1H-PYRROL-3-YL] METHANAMINE DERIVATIVE AND PHARMACEUTICAL COMPOSITION AND USE THEREOF | 2020-01-30 |
20200030307 | METHOD OF TREATMENT WITH TRADIPITANT | 2020-01-30 |
20200030308 | ANALOGS OF PRIDOPIDINE, THEIR PREPARATION AND USE | 2020-01-30 |
20200030309 | COMPOUNDS FOR INCREASING NEURAL PLASTICITY | 2020-01-30 |
20200030310 | NOVEL COMBINATIONS OF A H3 ANTAGONIST AND A NORADRENALINE REUPTAKE INHIBITOR, AND THE THERAPEUTICAL USES THEREOF | 2020-01-30 |
20200030311 | SUBSTITUTED PYRAZOLO[1,5-A]PYRIDINE COMPOUNDS AS RET KINASE INHIBITORS | 2020-01-30 |
20200030312 | Lactam Compound, Preparation Method and Use thereof | 2020-01-30 |
20200030314 | EARLY TREATMENT OF CMT DISEASE | 2020-01-30 |
20200030315 | SUBLINGUAL APOMORPHINE | 2020-01-30 |
20200030316 | BENZOIC ACID, BENZOIC ACID DERIVATIVES AND HETEROARYL CARBOXYLIC ACID CONJUGATES OF OXYMORPHONE, PRODRUGS, METHODS OF MAKING AND USE THEREOF | 2020-01-30 |
20200030317 | TAMPER-RESISTANT DOSAGE FORM WITH IMMEDIATE RELEASE AND RESISTANCE AGAINST SOLVENT EXTRACTION | 2020-01-30 |
20200030318 | PHARMACEUTICAL FORMULATIONS FOR SUSTAINED RELEASE OF SEBACOYL DINALBUPHINE ESTER | 2020-01-30 |
20200030319 | Dosing Regimens for Fast Onset of Antidepressant Effect | 2020-01-30 |
20200030320 | AQUEOUS COMPOSITION FOR EYE DROPS AND NASAL DROPS | 2020-01-30 |
20200030321 | TREAMENT OF T-CELL MEDIATED DISEASES | 2020-01-30 |
20200030322 | METHODS OF USING PYRUVATE KINASE ACTIVATORS | 2020-01-30 |
20200030323 | TREATING COGNITIVE DECLINE AND OTHER NEURODEGENERATIVE CONDITIONS BY SELECTIVELY REMOVING SENESCENT CELLS FROM NEUROLOGICAL TISSUE | 2020-01-30 |
20200030324 | KRAS G12C INHIBITORS AND METHODS OF USING THE SAME | 2020-01-30 |
20200030325 | Reverse Amide Compounds As Protein Deacetylase Inhibitors And Methods Of Use Thereof | 2020-01-30 |
20200030326 | 5-(PYRIMIDIN-4-YL)-2-(PYRROLIDIN-1-YL)NICOTINONITRILE COMPOUNDS AS IKKE, TBK1 AND/OR SIK2 KINASES INHIBITORS | 2020-01-30 |
20200030327 | ANTI-HIV COMPOUNDS | 2020-01-30 |
20200030328 | AZA-PYRIDONE COMPOUNDS AND USES THEREOF | 2020-01-30 |
20200030329 | METHOD FOR TREATING CANCER PATIENTS WITH SEVERE RENAL IMPAIRMENT | 2020-01-30 |
20200030330 | BRUTON'S TYROSINE KINASE INHIBITOR COMBINATIONS AND USES THEREOF | 2020-01-30 |
20200030331 | SUBSTITUTED PYRROLO[1,2-A]PYRIMIDINES AND THEIR USE IN THE TREATMENT OF MEDICAL DISORDERS | 2020-01-30 |
20200030332 | INHIBITOR AND ACTIVATOR OF DISCOIDIN DOMAIN RECEPTOR 1 AND THEIR USE | 2020-01-30 |
20200030333 | CRYSTALLINE SODIUM SALT OF 5-METHYL-(6S)-TETRAHYDROLIC ACID | 2020-01-30 |
20200030334 | PHARMACEUTICAL FORMULATIONS FOR THE TREATMENT OF DRY EYE AND METHODS FOR FABRICATING AND USING THEREOF | 2020-01-30 |
20200030335 | PLEUROMUTILIN DERIVATIVES FOR THE TREATMENT OF DISEASES MEDIATED BY MICROBES | 2020-01-30 |
20200030336 | ANTIBIOTIC COMPOSITIONS FOR NASAL IRRIGATION AND METHODS | 2020-01-30 |
20200030337 | DELIVERY OF ACTIVE AGENTS USING NANOFIBER WEBS | 2020-01-30 |
20200030338 | PHARMACEUTICAL COMPOSITIONS COMPRISING MELOXICAM | 2020-01-30 |
20200030339 | TREATMENT CANCERS USING A COMBINATION COMPRISING PARP INHIBITORS | 2020-01-30 |
20200030340 | DRUG THERAPY FOR PREVENTING OR TREATING GLAUCOMA | 2020-01-30 |
20200030341 | METHOD FOR THE TREATMENT OF DRAVET SYNDROME | 2020-01-30 |
20200030343 | ANTI-CANCER EFFECTS OF JAK2 INHIBITORS IN COMBINATION WITH THALIDOMIDE DERIVATIVES AND GLUCOCORTICOIDS | 2020-01-30 |
20200030344 | METHODS AND COMPOSITIONS RELATED TO GLUCOCORTICOID RECEPTOR ANTAGONISTS AND BREAST CANCER | 2020-01-30 |
20200030345 | VIRAL PROPHYLAXIS TREATMENT METHODS AND PRE-EXPOSURE PROPHYLAXIS KITS | 2020-01-30 |
20200030346 | PHARMACEUTICAL COMPOSITION COMPRISING DAPAGLIFLOZIN | 2020-01-30 |
20200030347 | ANTIMICROBIAL COMPOSITIONS | 2020-01-30 |
20200030348 | INHIBITORS OF SHORT-CHAIN DEHYDROGENASE ACTIVITY FOR TREATING CORONARY DISORDERS | 2020-01-30 |
20200030349 | PHYSIOLOGICALLY ACTIVE PREPARATION COMPRISING N-ACETYL-GLUCOSAMINE FOR THE TREATMENT OF BACK PAIN | 2020-01-30 |
20200030350 | Composition, For Remedying Female Climacteric Syndrome Symptoms, Comprising Tectorigenin 7-O-Xylosylglucoside | 2020-01-30 |
20200030351 | USE OF CARRIMYCIN AND PHARMACEUTICALLY ACCEPTABLE SALTS OF CARRIMYCIN IN MANUFACTURING MEDICAMENT FOR TREATING AND/OR PREVENTING TUMOR | 2020-01-30 |
20200030352 | METHOD FOR TREATING CROHN'S DISEASE USING TRIPLE ANTIMICROBIAL ALL-IN-ONE FORMULATION | 2020-01-30 |
20200030353 | STIMULATING PLATELET GENERATION BY ACTIVATING MITOCHONDRIAL BIOGENESIS | 2020-01-30 |
20200030354 | COMPOSITIONS AND METHODS FOR TREATING AN INFECTION | 2020-01-30 |
20200030355 | COMBINATION THERAPY FOR TREATING CANCER | 2020-01-30 |
20200030356 | PANCREATIC CANCER THERAPY AND DIAGNOSIS | 2020-01-30 |
20200030357 | Morpholino Oligonucleotides Useful In Cancer Treatment | 2020-01-30 |
20200030358 | USE OF VITAMIN COMPOSITION IN PREPARING DRUG FOR PREVENTING, TREATING, OR DELAYING ALZHEIMER'S DISEASE | 2020-01-30 |
20200030359 | INHIBITION OF STRESS GRANULE FORMATION THROUGH MANIPULATION OF UBAP2L | 2020-01-30 |
20200030360 | -1,6-GLUCAN THERAPEUTIC ANTIBODY CONJUGATES | 2020-01-30 |
20200030361 | OLIGONUCLEOTIDES CONTAINING 2'-DEOXY-2'FLUORO-BETA-D-ARABINOSE NUCLEIC ACID (2'-FANA) FOR TREATMENT AND DIAGNOSIS OF RETROVIRAL DISEASES | 2020-01-30 |
20200030362 | NITRIC OXIDE-RELEASING POLYAMINOGLYCOSIDES AS BIODEGRADABLE ANTIBACTERIAL SCAFFOLDS AND METHODS PERTAINING THERETO | 2020-01-30 |
20200030363 | COMPOSITIONS OF HYALURONAN WITH HIGH ELASTICITY AND USES THEREOF | 2020-01-30 |
20200030364 | HIGH ELASTICITY HYALURONAN COMPOSITIONS AND METHODS OF USE THEREOF | 2020-01-30 |
20200030365 | PHARMACEUTICAL COMPOSITIONS WITH HYDRATING AND LUBRICATING ACTIVITY | 2020-01-30 |
20200030366 | INULIN FOR PREVENTING ANTIBIOTIC RESISTANT INFECTION AND PATHOGEN COLONIZATION | 2020-01-30 |
20200030367 | COMPOSITION FOR TREATING FIBROCARTILAGE TISSUE DAMAGE | 2020-01-30 |
20200030368 | A POLYMER NETWORK, METHOD FOR PRODUCTION, AND USES THEREOF | 2020-01-30 |
20200030369 | Modified Immune-Modulating Particles | 2020-01-30 |
20200030370 | METHOD FOR TREATING SCHIZOPHRENIA | 2020-01-30 |
20200030371 | METHOD OF ADMINISTRATION AND TREATMENT | 2020-01-30 |
20200030372 | ALLEVIATING COMMON COLD AND INFLUENZA SYMPTOMS WITH MOLECULAR HYDROGEN | 2020-01-30 |
20200030373 | COMPOSITIONS AND METHODS FOR INTRACELLULAR IRON DISPLACEMENT PROTEINS | 2020-01-30 |
20200030374 | CELLULAR TARGETED ACTIVE INGREDIENT DELIVERY SYSTEM | 2020-01-30 |
20200030375 | THERAPY AND METHODS OF INTRODUCING IMMATURE DENDRITIC CELLS AND/OR CYTOXIC T LYMPHOCYTE AND ANTI PD-1 / PD-L1 ANTIBODY FOR TREATMENT OF TUMORS | 2020-01-30 |
20200030376 | CELL THERAPY COMPOSITION FOR PREVENTING OR TREATING NEURODEGENERATIVE DISEASE COMPRISING REGULATORY T CELLS AS ACTIVE INGREDIENT | 2020-01-30 |
20200030377 | ANTIGEN-SPECIFIC IMMUNE MODULATION | 2020-01-30 |
20200030378 | HIGH AFFINITY MERKEL CELL POLYOMAVIRUS T ANTIGEN-SPECIFIC TCRS AND USES THEREOF | 2020-01-30 |
20200030379 | CELL EXPRESSING A CAR AND A TRANSCRIPTION FACTOR AND ITS USE | 2020-01-30 |
20200030380 | STIMULATION OF THERAPEUTIC ANGIOGENESIS BY T REGULATORY CELLS | 2020-01-30 |
20200030381 | COMPOSITIONS AND METHODS FOR INHIBITION OF LINEAGE SPECIFIC PROTEINS | 2020-01-30 |
20200030382 | METHODS FOR LOWERING BLOOD GLUCOSE | 2020-01-30 |
20200030383 | PANCREATIC ENDOCRINE CELLS AND METHODS THEREOF | 2020-01-30 |
20200030384 | COMPOSITIONS AND METHODS FOR PROVIDING HEMATOPOIETIC FUNCTION | 2020-01-30 |
20200030385 | Water resistant enhanced wound healing film and preparation method thereof | 2020-01-30 |
20200030386 | COMPOSITION HAVING HYDROLYZED COLLAGEN AND MANUKA HONEY | 2020-01-30 |
20200030387 | BACTERIAL SECRETOME FOR USE IN THE TREATMENT OF SKIN LESIONS | 2020-01-30 |
20200030388 | COMPOSITIONS FOR MODIFYING GUT MICROBIOTA | 2020-01-30 |
20200030389 | Pharmaceutical Compositions Comprising a Blautia Strain | 2020-01-30 |
20200030390 | MICROORGANISMS INHIBITING THE FORMATION OF AXILLARY MALODOR | 2020-01-30 |